This section of the site includes press releases and statements issued by the MHRA.
The opening hours for the Press Office are Monday to Friday between 9:00 and 17:00.
The Press Office
5th Floor
151 Buckingham Palace Road
Victoria
LONDON
SW1W 9SZ
Main telephone: 020 3080 7651
Out of hours: 07770 446 189
press.office@mhra.gsi.gov.uk
For urgent calls outside these press office hours please contact the duty press officer on : 07770 446 189.
We now have a Twitter channel for press releases and news statements, giving you another way to find out the latest news from the MHRA in real time.
Follow @MHRAGovUkPress
Press enquiries should be made through the Press Office.
Latest press releases
-
08 Feb 2012 | Press release: Two men sentenced for illegal online sale of Prescription Only Medicines and Class C steroids
Two men were sentenced yesterday at Chelmsford Crown Court for their involvement in the illegal online sale and supply of prescription-only medicines and numerous anabolic steroids.
-
08 Feb 2012 | Press release: MHRA welcomes a new Director of Medical Devices
John Wilkinson OBE joins the Medicines and Healthcare products Regulatory Agency (MHRA) as Director of Medical Devices this week.
-
08 Feb 2012 | Press release: New appointments to the British Pharmacopoeia Commission
The British Pharmacopoeia (BP) Commission and the Appointments Commission are pleased to announce the appointment of five new members to the BP Commission.
-
01 Feb 2012 | Press release: Unlicensed herbal remedy could cause liver and organ damage
The MHRA has advised that people should stop using butterbur, an unlicensed herbal product that could cause serious liver damage and organ failure.
-
16 Jan 2012 | Press release: Product recall of saline nasal spray due to bacterial contamination
The MHRA has received warning of possible bacterial contamination in batches of the saline nasal spray Sterimar Isotonic 100ml. The spray is sold online and at high street retailers and is commonly used to cleanse the nasal passage.
-
23 Dec 2011 | Press statement: PIP breast implants – UK medical devices regulator says no evidence to support routine removal
Following the announcement in France today, the MHRA is not recommending routine removal of Poly Implant Prosthese (PIP) silicone gel breast implants in the UK.
-
19 Dec 2011 | Press release: UK medicines and medical devices regulator awards first elective prize for medical students
A Kings College Medical School student with a special interest in hip replacement surgery is the recipient of the Medicine and Healthcare products Regulatory Agency’s (MHRA) first Trainee Doctors Advisory Board (TRAB) elective prize.
-
09 Dec 2011 | Press release: UK regulator warns of the importance of using registered herbal medicines after discovering super-strength menopause remedy
The MHRA is urging consumers that natural does not always mean safe following a safety notice issued for FSC Black Cohosh 1000mg capsules, an unlicensed herbal remedy commonly used to relieve menopausal symptoms.
-
23 Nov 2011 | Press release: Cancer drugs precautionary recall - UK medicines regulator issues drug alerts
The MHRA has today issued drug alerts to hospitals, clinics and wholesalers about some batches of the cancer drugs Busilvex and Velcade, used to treat bone marrow cancer, following a precautionary recall concerning a theoretical risk of contamination.
-
22 Nov 2011 | Press release: Cancer drugs recall
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended a recall of three drugs used in cancer therapy following an inspection of a US manufacturing site that highlighted several quality assurance problems in the sterilisation process.
